The STARD (STAndards for Reporting Diagnostic Accuracy) - Checklist
02 Jul 2018
The STARD guideline was developed to provide select items that would improve the quality of diagnostic research. The reporting of these items facilitates the reader in identifying the potential bias in the study or to appraise the applicability of the study findings, and validity of the conclusions and recommendations. The 30-item STARD checklist was identified by an international expert group of methodologists, researchers, and editors and its updated version was published in 2015 after its first publication in 2003.
Item No | Item Description | Applicable to Section | Page no. where reported |
1 | By using at least one measure of accuracy (such as | TITLE OR ABSTRACT | |
2 | Structured summary of study design, methods, results, and | ABSTRACT | |
3 | Provide scientific and clinical background, including the | INTRODUCTION | |
4 | Detail study objectives and hypotheses | ||
5 | Mention the type of study – prospective or retrospective | METHODS – Study Design | |
6 | Define eligibility criteria | METHODS – Participants | |
7 | Provide basis of identification of potentially eligible | ||
8 | Mention date, location and setting for identification of | ||
9 | Mention whether participants formed a consecutive, random | ||
10a | Include sufficient details of index test to allow | METHODS – Test Methods | |
10b | Include sufficient details of reference standard to allow | ||
11 | Give rationale for choosing the reference standard (if | ||
12a | Give rationale and define the cut-offs or result categories | ||
12b | Give rationale and define the cut-offs or result categories | ||
13a | State whether the performers/readers of the index test were | ||
13b | State whether the assessors of the reference standard were | ||
14 | Methods for estimating or comparing measures of diagnostic | METHODS – Analysis | |
15 | Mention the methods for handling of indeterminate index | ||
16 | Mention the methods for handling of missing data on the | ||
17 | Analyses of variability in diagnostic accuracy, | ||
18 | Explain the determination of intended sample size | ||
19 | Provide participant flow of diagram | RESULTS – Participants | |
20 | Provide baseline demographic and clinical characteristics | ||
21a | Classify the severity of disease in those with the target | ||
21b | Mention any alternative diagnoses in those without the | ||
22 | State the time interval and any clinical interventions | ||
23 | Provide cross tabulation of the index test results (or | RESULTS – Test Results | |
24 | Give the estimates of diagnostic accuracy and their | ||
25 | Report any adverse events | ||
26 | Mention study limitations, including sources of potential | DISCUSSION | |
27 | Clinical implications including the intended use and | ||
28 | Provide the registration number and name of registry | OTHER INFORMATION | |
29 | Mention the location to access the full study protocol | ||
30 | Sources of funding and other support; role of funders to be |